Abstract
Without direct comparison or randomized controlled trials, two experts square off on the difficult choice of trying to reduce the usage of one of two drugs with well-known side effects after kidney transplantation.
Original language | English (US) |
---|---|
Pages (from-to) | 3026-3030 |
Number of pages | 5 |
Journal | Journal of the American Society of Nephrology |
Volume | 18 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2007 |